publication venue for
- Viruses - a major cause of amyloid deposition in the brain.. 23:775-790. 2023
- Considering patient age when treating multiple sclerosis across the adult lifespan.. 21:353-364. 2021
- MRI biomarkers of disease progression and conversion to secondary-progressive multiple sclerosis.. 20:821-834. 2020
- Vascular aspects of multiple sclerosis: emphasis on perfusion and cardiovascular comorbidities.. 19:445-458. 2019
- Targeting neuroinflammation in Alzheimer's disease: evidence for NSAIDs and novel therapeutics.. 17:17-32. 2016
- Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.. 16:777-93. 2016
- Building a roadmap for developing combination therapies for Alzheimer's disease.. 15:327-33. 2015
- Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication.. 15:7-17. 2014
- The role of neuroendocrine pathways in prognosis after stroke.. 14:217-32. 2014
- Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?. 6:1293-306. 2006